Centenarian blood chemistry, a muscle-aging switch, fasting made easier, and four other things worth your time this week.

Week of July 10th, 2026

This week’s research keeps circling one theme: the difference between what sounds actionable and what actually is. We dig into the blood chemistry that sets centenarians apart (and why you can’t supplement your way to it), a molecular “switch” that explains how exercise reverses muscle aging, with a catch about timing that should change how you think about training in midlife, and a head-to-head trial on whether intermittent fasting really beats calorie counting. Plus: the deep-sleep circuit that quietly builds muscle and burns fat, creatine’s surprising turn against cancer, why some brains resist Alzheimer’s even with the disease present, and a dosing mistake sending thousands of GLP-1 users to poison control. Seven findings, graded honestly. Here’s what’s worth your attention.

1. Centenarians Carry a Distinct Blood Signature — and It Isn’t Just “Aging Slower”

What separates people who reach 100 in good health from the rest of us may be written in their blood chemistry. Boston University’s New England Centenarian Study, published in GeroScience, ran untargeted metabolomics on more than 1,400 molecules in 213 people, centenarians averaging 105, their offspring, and matched controls, then cross-checked the pattern against four other cohorts. Extreme-longevity individuals showed higher primary and secondary bile acids (notably chenodeoxycholic and lithocholic acid), lower biliverdin and bilirubin, and preserved steroid levels. Higher bile acids and steroids tracked with lower mortality.

Read it as a map, not a menu. This is cross-sectional human data: it identifies chemical fingerprints associated with long life, not levers you can pull. You can’t supplement your way to a centenarian’s metabolome, and genetics accounts for roughly half of reaching extreme age. But it points research toward bile-acid and gut-metabolism pathways worth watching.

Monti S, Lustgarten MS, Sebastiani P, et al. Metabolomic signatures of extreme old age: findings from the New England Centenarian Study. GeroScience. 2026. DOI: 10.1007/s11357-026-02174-2. https://link.springer.com/article/10.1007/s11357-026-02174-2

2. Exercise Flips a Molecular “Switch” That Reverses Muscle Aging

Researchers at Duke-NUS Medical School, working with Cardiff University, identified a gene called DEAF1 that helps explain why aging muscle loses its ability to repair itself, and why exercise pushes back. Published in PNAS, the work shows DEAF1 climbs in aging muscle, driving mTORC1 activity out of balance and tipping cells away from repair. A family of proteins called FOXOs normally keeps DEAF1 in check, but FOXO activity fades with age. Physical activity lowers DEAF1 and restores the balance.

This is mechanistic work in lab models, not a human training trial, so treat the specifics as biology rather than a prescription. One caveat carries a real-world lesson: in muscle that’s already severely aged, with DEAF1 extremely high or FOXO collapsed, exercise alone may not fully restore repair. The takeaway isn’t new, keep training, but the timing argument is sharper. Consistency through midlife protects the system while it’s still responsive. Maybe someday there will be a molecule or peptide to take to help this imbalance.

Exercise reverses muscle aging via DEAF1 regulation. Proceedings of the National Academy of Sciences (Duke-NUS Medical School). July 2026. https://www.sciencedaily.com/releases/2026/06/260623014026.htm

3. Intermittent Fasting Isn’t Magic, But It May Be Easier to Stick With

A useful head-to-head from the University of Adelaide, published in Clinical Nutrition, followed more than 200 adults with obesity for 18 months across three groups: intermittent fasting paired with time-restricted eating, continuous calorie restriction, and standard healthy-eating advice. Fasting and calorie restriction produced similar weight loss, roughly 7 kg at six months versus about 2 kg with standard care. The difference was mental effort: the fasting group didn’t report the same constant restraint around food, and the researchers estimated that behavioral self-control accounted for about 15% of the calorie-restriction group’s results.

The honest framing: fasting wasn’t metabolically superior, weight loss was comparable. Its edge is adherence, which matters most for people caught in the lose-it-regain-it cycle. Findings come from adults with obesity, so they may not transfer neatly to leaner people simply chasing recomposition.

Teong XT, Heilbronn LK, et al. Intermittent fasting plus time-restricted eating versus calorie restriction on eating behavior, mood, sleep, and quality of life in adults with obesity. Clinical Nutrition. 2026. DOI: 10.1016/j.clnu.2026.106686. https://www.sciencedaily.com/releases/2026/07/260701015247.htm

4. Scientists Mapped the Deep-Sleep Circuit That Builds Muscle and Burns Fat

If you needed another reason to protect your sleep, here it is. A UC Berkeley and Stanford team, publishing in Cell, mapped the brain circuit that ties deep, non-REM sleep to growth hormone release. Two hypothalamic signals, GHRH acting as the accelerator, somatostatin as the brake, coordinate the hormone surge that supports muscle repair, fat metabolism, and bone. Growth hormone then loops back to help regulate when you wake and drift off. It’s a feedback system, which helps explain why fragmented sleep undercuts recovery and metabolism.

This is circuit-level work in animals, so it explains mechanism rather than testing a sleep intervention in people. And the takeaway is emphatically not growth-hormone supplementation, which carries real risks. It’s the unglamorous version: guard your deep sleep with a consistent schedule, a cool dark room, and a gap between your last drink or meal and bedtime. I also know this question is going to come up. Tesamorelin, sermorelin, and CJC-1295 have a coherent mechanistic argument for supporting the accelerator side of this circuit, and older human data support GHRH's direct SWS-promoting effect. Ipamorelin's mechanism doesn't map onto the GHRH side of the story at all, and the ghrelin-receptor data on sleep architecture is thinner and mixed. None of this has been tested against the specific circuit this paper describes, and the paper itself explicitly stops short of endorsing supplementation, its stated takeaway is protecting natural deep sleep, not replacing it. [Unknown] Whether any of these compounds' pulsatile timing matches the circuit closely enough to help rather than blunt it is an open question.

Ding X, Dan Y, et al. Neuroendocrine circuit for sleep-dependent growth hormone release.Cell. 2025. DOI: 10.1016/j.cell.2025.05.039. https://www.sciencedaily.com/releases/2026/06/260626030433.htm

5. Creatine’s Résumé Grows — This Time Against Cancer

Creatine, the most-studied strength supplement on the shelf, keeps turning up in unexpected places. A UCLA study in iScience found that dendritic cells, the immune sentinels that flag tumors and switch on killer T cells, ramp up their creatine intake inside the nutrient-starved tumor environment and lean on it for energy. Supplying creatine boosted those cells’ activation, slowed tumor growth in mouse melanoma, and energized human dendritic cells in a dish. Since only about 20–40% of patients respond to current immunotherapies, strengthening this arm of the response is a meaningful target.

Grade it carefully: this is preclinical, in mice and cells, and explicitly untested in humans for cancer. It does not mean creatine treats or prevents cancer. Creatine’s proven value remains muscle and strength, with a growing but still-preliminary cognitive literature. File this as an intriguing mechanism, not a new reason to dose. I recommend 10 g of creatine monohydrate per day.

Kang E, Yang L, et al. Creatine uptake promotes dendritic cell activation and enhances antitumor immunity. iScience. 2026. DOI: 10.1016/j.isci.2026.115436. https://www.cell.com/iscience/fulltext/S2589-0042(26)00811-4

6. Why Some Brains Resist Alzheimer’s Even With the Disease Present

One of the field’s deepest puzzles is why some people carry full Alzheimer’s pathology yet stay mentally sharp. A study from the Netherlands Institute for Neuroscience in Cell Stem Cell offers a clue from human hippocampal tissue. The researchers profiled immature neurons, young, still-developing brain cells, in aged brains. In cognitively resilient people, it wasn’t that these cells were more numerous. It was how they behaved: they switched on pro-survival genes and dialed down signals tied to inflammation and cell death.

This is descriptive human tissue work, not a treatment, so there’s nothing to act on yet. Its value is directional. If resilience comes from how vulnerable cells respond to damage rather than simply how much damage accumulates, that reframes where dementia therapies might aim, toward supporting the cells that survive, not only clearing what’s toxic.

Tosoni G, Salta E, et al. Transcriptional profiles of immature neurons in aged human hippocampus track Alzheimer’s pathology and cognitive resilience. Cell Stem Cell. 2026. DOI: 10.1016/j.stem.2026.04.002. https://www.sciencedaily.com/releases/2026/06/260626125709.htm

7. The Ozempic Mistake Sending Thousands to Poison Control

A practical safety note for anyone using or starting a GLP-1. Researchers at UT San Antonio, publishing in the Journal of Medical Toxicology, analyzed national poison-center data from 2012 to 2023 and found calls involving these drugs climbed from roughly 1,500 to about 8,000 a year after semaglutide’s 2021 obesity approval, with semaglutide accounting for 64% of them. The surge came overwhelmingly from avoidable dosing errors, not misuse. The two most common: injecting daily instead of weekly, and starting at a full dose instead of titrating up gradually.

Most cases were mild gastrointestinal upset, but the share referred to a healthcare facility

rose from 23% to 33.5%. Compounded versions sold as vials with separate syringes are especially error-prone, enabling large overdoses. If you’re on one of these: it’s weekly, not daily; ramp up slowly; and keep a simple dose log.

Miller J, et al. National Poison Center Trends in GLP-1 Receptor Agonist Exposures Following FDA Approval for Weight Loss. Journal of Medical Toxicology. 2026. DOI: 10.1007/s13181-026-01121-z. https://link.springer.com/article/10.1007/s13181-026-01121-z

Have a great week,

Dr. Smith and Winston

Medical disclaimer

The content above is for informational and educational purposes only and does not constitute medical, nutritional, or professional advice. It is not intended to diagnose, treat, cure, or prevent any disease and is not a substitute for personalized guidance from a licensed physician or other qualified healthcare provider. Individual needs and risks vary. Do not begin, stop, or modify any exercise regimen, training intensity, dietary plan, medication, or supplement (including creatine) based on this article alone. Consult your doctor first — particularly if you have or suspect a cardiovascular, metabolic, musculoskeletal, kidney, or neurological condition, take prescription medications, are pregnant or breastfeeding, or are new to vigorous exercise. If you experience chest pain, severe shortness of breath, dizziness, or other concerning symptoms during activity, stop and seek medical attention. Studies summarized here vary in design and quality; associations reported in observational research do not prove cause and effect.